Search

everythinglearnresearchcommunity

for

Search:↓

A new mouse gene, Keratin 17n, is mainly found in nail tissue and may explain why mice without Keratin 17 don't have nail issues.

Revertant cell therapy shows promise for treating type XVII collagen deficiency, but better cell selection methods are needed.

Interleukin-1 increases keratin K6 production in skin cells.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Ixekizumab effectively treats generalized pustular psoriasis.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

Different body areas have unique skin cell communication patterns, explaining why certain skin diseases occur in specific regions.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

LncRNA018392 helps goat skin cells grow by increasing CSF1R.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

A variant in the ADAM17 gene causes hair loss by increasing protein degradation through TRIM47.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

Higher levels of certain proteins may increase or decrease rosacea risk.

Targeting PTEN can improve healing in venous leg ulcers.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Cholecystokinin may help reduce skin inflammation in psoriasis.